Prescription RequiredRUCAPARIB 300 mg (Nuparp) is a prescription targeted anticancer medicine used to treat certain ovarian, fallopian tube, and primary peritoneal cancers. It belongs to a class of medicines called PARP inhibitors and works by preventing cancer cells from repairing damaged DNA, which can lead to their destruction. It is taken orally under the supervision of an oncologist.
| Generic name | RUCAPARIB |
| Strength | 300 mg |
| Manufacturer | Zydus |
| Package size | 60 Tablets |
| Used for | Ovarian, fallopian tube, and primary peritoneal cancers |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Rucaparib 300 mg works by inhibiting poly (ADP-ribose) polymerase (PARP) enzymes, which help repair damaged DNA. In cancer cells with BRCA mutations or other DNA-repair defects, blocking PARP prevents effective DNA repair. This causes damage to accumulate within the cancer cells, which can lead to cell death and help limit tumour growth.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
